{
    "code": "60000973",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000973",
    "time": "2020-03-13 06:32:14",
    "許可證字號": "衛部菌疫輸字第000973號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/04\/20",
    "發證日期": "104\/04\/20",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000097303",
    "中文品名": "癌即瓦注射劑",
    "英文品名": "Gazyva solution for infusion",
    "適應症": "1.\t慢性淋巴球性白血病\r\n與chlorambucil 併用，適用於先前未曾接受過治療，且具有合併症(comorbidities)而不適合接受含fludarabine治療的CD20陽性慢性淋巴球性白血病(CLL)患者。\r\n\r\n2.\t濾泡性淋巴瘤\r\n與化療藥物併用作為誘導治療，並續以Gazyva單藥維持治療，適用於先前未曾接受過治療的濾泡性淋巴瘤(FL)患者。\r\n與bendamustine併用並續以Gazyva單藥維持治療，適用於先前曾接受含rituximab治療無效或復發的濾泡性淋巴瘤(FL)患者。",
    "劑型": "27D注射液劑",
    "包裝": "玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "Obinutuzumab",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0261000  ROCHE DIAGNOSTICS GMBH",
            "製造廠廠址": "SANDHOFER STRASSE 116, 68305 MANNHEIM, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FCH0257000  F. HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FDE0343000  ROCHE DIAGNOSTICS GMBH",
            "製造廠廠址": "NONNENWALD 2, D-82377 PENZBERG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013004400",
            "成分名稱": "Obinutuzumab",
            "含量描述": "",
            "含量": "1000.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Gazya_10156835_LAB-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000973&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "癌即瓦注射劑_0219-GAZ-01(385x530mm)-108-03-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000973&Seq=005&Type=9"
        },
        {
            "title": "000973中文仿單-107-08-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000973&Seq=004&Type=9"
        },
        {
            "title": "Gazyva_000973-1-STK-02-108-03-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000973&Seq=004&Type=8"
        },
        {
            "title": "Gazyva針劑標籤-104-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000973&Seq=003&Type=8"
        }
    ]
}